Related Experiment Video
Updated: Sep 27, 2026

A Protocol for Analyzing Hepatitis C Virus Replication
Published on: June 26, 2014
Hepatitis C virus: clades and properties
1Department of Pathology and Infectious Diseases, Royal Veterinary College, University of London, London, UK. choward@rvc.ac.uk
Insights
Hepatitis C virus (HCV) comprises six clades, with Clades 1 and 2 being most common globally. Understanding HCV clade distribution is crucial for vaccine development and studying viral evolution.
Area of Science:
- Virology
- Hepatology
- Immunology
Background:
- Hepatitis C virus (HCV) is a Flaviviridae family member, classified into six distinct clades.
- HCV exhibits limited homology with Hepatitis G/GB viruses, and clade variability is less than dengue serotypes.
- Global distribution of HCV clades varies, with Clades 1 and 2 predominating in most regions.
Purpose of the Study:
- To analyze the classification, genetic variability, and global distribution of Hepatitis C virus (HCV) clades.
- To explore the implications of HCV clade distribution for vaccine development and epidemiological studies.
- To investigate the role of viral evolution, particularly in the E2 hypervariable region, in HCV immunity and treatment outcomes.
Main Methods:
- Genome sequencing to classify HCV into six clades and subtypes.
- Comparative analysis of genetic variability among HCV clades and other flaviviruses.
- Epidemiological data analysis to determine global and age-specific clade distribution.
- Studies in chimpanzees to examine the role of the E2 hypervariable region in HCV immunity.
- Analysis of the NS5 gene for IFN-sensitive motifs to predict treatment outcomes.
Main Results:
- HCV is classified into six clades, with subtypes within each clade.
- Clades 1 and 2 are the predominant HCV types globally, with variations in distribution across different regions and age groups.
- The E2 hypervariable region shows rapid evolution during developing immunity, suggesting a role in immune evasion.
- An IFN-sensitive motif in the NS5 gene may predict the outcome of interferon treatment for Hepatitis C.
Conclusions:
- HCV clade classification and distribution are critical for understanding viral epidemiology and developing effective vaccines.
- Viral evolution, particularly in the E2 region, influences HCV immunity.
- Identifying specific genetic motifs, like the IFN-sensitive motif in NS5, can aid in predicting treatment responses for Hepatitis C.
Abstract:
Hepatitis C virus (HCV) is a member of the virus family Flaviviridae. At present HCV is classified into a discrete hepacivirus genus and is represented by six clades according to genome sequencing. Each clade is further divisible into subtypes, which may prove important for the study of clinical differences and epidemiological studies. Limited homology also exists with hepatitis G/GB viruses, despite the fact that the hepatotropic nature of the latter agents remains contentious. The variability amongst the six HCV clades is less than that observed between the four serotypes of dengue, suggesting that each clade may represent a distinct virus were tests such as plaque neutralization to become available for delineating HCV isolates. The distribution worldwide varies, with Clades 1 and 2 predominating in most regions-an important consideration for the development of any vaccine. In addition, the clade distribution among cohorts may vary according to age. Point source outbreaks of HCV, for example in large numbers of women inadvertently infected with HCV-contaminated anti-D globulin, offers an opportunity to study the evolution of HCV genotypes over several decades. Parallel studies in chimpanzees have shown that the hypervariable region of E2 may play a role in HCV immunity, with quasispecies rapidly replacing the predominant subtype as immunity develops to the initiating virus strain. There is some evidence that an IFN-sensitive motif exists in the NS5 gene which may have some predictive value in determining the likely outcome of IFN treatment. A database is available for all HCV sequences, together with information about their properties and guidance for the evaluation of new isolates (http://s2as02.genes.nig.ac.jp).
Related Concept Videos
Hepatitis
Viral Hepatitis I: Introduction
Subviral Agents
Cytomegalovirus Disease
Cirrhosis I: Introduction
Bacterial Phylum Chlamydiae

